Puma Biotechnology (NASDAQ:PBYI) reported quarterly earnings of $0.29 per share which beat the analyst consensus estimate of $0.23 by 27.75 percent. This is a 32.56 percent decrease over earnings of $0.43 per share from the same period last year. The company reported quarterly sales of $75.500 million which beat the analyst consensus estimate of $68.600 million by 10.06 percent. This is a 27.75 percent increase over sales of $59.100 million the same period last year.

• No comments yet. Be the first to comment!